novo nordisk glp 1 GLP-1 RA education Details of failed studies cast

There is a boxed warning in prescribing information for the GLP-1 drug class regarding thyroid C-cell tumors observed in animal studies - this has led to GLP-1 medications being contraindicated in patients with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2

Available from: Nguyen TMD

Gamboa, J.L

How long should I stay on a GLP-1 medication

South America Prescription Drug Market Opportunities 3.2.5.4

Recommended protocol: Washout: 25 to 30 days Starting dose: 2mg weekly Week 5: escalate to 4mg Week 9: escalate to 8mg Week 13: escalate to 12mg based on response This accelerated schedule saves 4 weeks compared to the standard titration